Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - SYNOVUS FINANCIAL CORP | g23227e8vk.htm |
| EX-4.2 - EX-4.2 - SYNOVUS FINANCIAL CORP | g23227exv4w2.htm |
| EX-4.1 - EX-4.1 - SYNOVUS FINANCIAL CORP | g23227exv4w1.htm |
| EX-4.3 - EX-4.3 - SYNOVUS FINANCIAL CORP | g23227exv4w3.htm |
| EX-5.1 - EX-5.1 - SYNOVUS FINANCIAL CORP | g23227exv5w1.htm |
| EX-1.1 - EX-1.1 - SYNOVUS FINANCIAL CORP | g23227exv1w1.htm |
| EX-1.2 - EX-1.2 - SYNOVUS FINANCIAL CORP | g23227exv1w2.htm |
Exhibit 99.1
The estimated expenses incurred by Synovus Financial Corp. in connection with its issuance
and sale on May 4, 2010 of 293,250,000 shares of common stock of the Company, $1.00 par value per
share (“Common Stock”), and 13,800,000 tangible equity units (“tMEDS”) are set forth in the
following table:
Securities and Exchange Commission Registration Fee for Common Stock
offering |
$ | 57,499 | ||
Securities and Exchange Commission Registration Fee for tMEDS offering |
$ | 24,599 | ||
Printing and Engraving Expenses |
$ | 120,000 | ||
Accounting Fees and Expenses |
$ | 375,000 | ||
Legal Fees and Expenses |
$ | 1,400,000 | ||
Listing Fees and Expenses |
$ | 500,000 | ||
Miscellaneous Fees and Expenses |
$ | 22,902 | ||
Total |
$ | 2,500,000 |